Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Acorda Therapeutics is a publicly traded NASDAQ: ACOR biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions.
| Last: | $0.0135 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.0135 |
| Close: | $0.0135 |
| High: | $0.0135 |
| Low: | $0.0135 |
| Volume: | 3,729 |
| Last Trade Date Time: | 08/21/2024 03:00:00 am |
| Market Cap: | $16,768 |
|---|---|
| Float: | 1,209,803 |
| Insiders Ownership: | 0.62% |
| Institutions: | 6 |
| Short Percent: | 8102% |
| Industry: | Pharmaceuticals |
| Sector: | Healthcare |
| Website: | https://www.acorda.com/ |
| Country: | US |
| City: | Pearl River |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Acorda Therapeutics Inc. (OTCMKTS: ACORQ).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
